Welgus Howard G. Insider Trading Activity
Welgus Howard G. has been net-selling over the last 12 months with 0 purchases and 12 sales across 1 company.
ARQT is the most-traded position with 12 trades. The largest single transaction was a sale of ARQT for $302K on Dec 1, 2025.
Performance Scorecard
Forward stock performance after each transaction by Welgus Howard G.. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -8.4% | 43% | 14 |
| 90 days | — | -27.2% | 31% | 13 |
| 120 days | — | -38.5% | 33% | 12 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersARQT · Arcutis Biotherapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Welgus Howard G. bought and sold ARQT.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 1, 2026 | ARQT | Sell | 7,144 | $22.99 | $164K | −18.0% | Director | |
Apr 1, 2026 | ARQT | Sell | 10,000 | $23.88 | $239K | −20.1% | Director | |
Mar 2, 2026 | ARQT | Sell | 10,000 | $25.65 | $257K | −16.7% | Director | |
Feb 2, 2026 | ARQT | Sell | 10,000 | $25.05 | $250K | −14.3% | Director | |
Jan 2, 2026 | ARQT | Sell | 10,000 | $28.96 | $290K | −12.5% | Director | |
Dec 1, 2025 | ARQT | Sell | 10,000 | $30.21 | $302K | −11.1% | Director | |
Nov 3, 2025 | ARQT | Sell | 10,000 | $25.27 | $253K | −10.0% | Director | |
Oct 1, 2025 | ARQT | Sell | 9,538 | $18.92 | $180K | −8.7% | Director | |
Oct 1, 2025 | ARQT | Sell | 462 | $18.92 | $9K | −0.5% | Director | |
Sep 2, 2025 | ARQT | Sell | 10,000 | $15.64 | $156K | −9.1% | Director | |
Aug 1, 2025 | ARQT | Sell | 6,110 | $14.30 | $87K | −5.7% | Director | |
Aug 1, 2025 | ARQT | Sell | 3,890 | $14.30 | $56K | −3.7% | Director | |
Jul 1, 2025 | ARQT | Sell | 9,208 | $13.84 | $127K | −8.4% | Director | |
Jun 18, 2025 | ARQT | Sell | 10,139 | $13.37 | $136K | −8.5% | Director |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | 14 | $2.5M |
Other insiders at Arcutis Biotherapeutics, Inc.
6 other tracked filers at ARQT.